市場調查報告書
商品編碼
1470853
內視鏡再處理市場:依產品、最終用戶分類 - 2024-2030 年全球預測Endoscope Reprocessing Market by Product (Automated Endoscope Reprocessors, Detergents & Wipes, Endoscope Drying, Storage, & Transport Systems), End-User (Ambulatory Surgical Centers & Clinics, Hospitals) - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年內視鏡再處理市場規模為31.7億美元,2024年達34.5億美元,預計2030年將達58.3億美元,複合年成長率為9.08%。
內視鏡再處理是一項重要的滅菌程序,旨在降低使用之間的感染風險。內視鏡是一根帶有燈和攝影機的軟性管,用於觀察人的胃腸道內部。使用後,內視鏡必須徹底清洗和消毒,以消除微生物污染。胃腸道疾病、癌症和心血管疾病等需要內視鏡檢查的疾病的盛行率不斷上升,正在推動內視鏡再處理市場的成長。隨著手術數量的增加,對再加工內視鏡的需求也增加。具有增強消毒和清洗能力的現代自動化再處理設備提高了感染控制程序的有效性。此類進步可以輕鬆滿足醫療保健環境中對病人安全和衛生日益成長的需求。食品藥物管理局(FDA) 和疾病管制中心 (CDC) 等監管機構已將其標準集中在內視鏡再處理上,重點關注感染控制和預防。醫療機構嚴格執行這些法規可確保內視鏡再處理的安全和標準化實踐,從而推動市場成長。然而,開拓內視鏡再處理解決方案的高成本阻礙了市場成長。更多引進技術先進的內視鏡再處理解決方案預計將創造市場成長機會。
主要市場統計 | |
---|---|
基準年[2023] | 31.7億美元 |
預測年份 [2024] | 34.5億美元 |
預測年份 [2030] | 58.3億美元 |
複合年成長率(%) | 9.08% |
擴大清潔劑和擦拭巾的使用,以防止產品生物膜積聚並確保全面消毒
自動化內視鏡再處理機 (AER) 透過標準化消毒流程、加強感染控制和降低污染風險,徹底改變了內視鏡再處理產業。儘管效率不斷提高,但仍需要進行詳細研究來評估 AER 的採用水準、成本效益和技術進步。清洗和擦拭巾透過防止生物膜累積並確保全面消毒,為內視鏡再處理過程提供重要支援。生物相容性、功效和易用性等因素對市場動態的影響需要徹底檢驗。內視鏡乾燥、儲存和運輸系統本質上與減少內視鏡再處理相關的感染疾病有關。內視鏡追蹤解決方案可增強庫存管理、提高病患安全並增強資料記錄和共用功能。對這些解決方案的詳細評估揭示了將推動未來市場趨勢的潛在成長領域、客戶需求和技術進步。高水準消毒劑和試紙在確保內視鏡無菌方面發揮著至關重要的作用。
最終用戶:醫院更採用內視鏡再處理,重點在於有效的感染控制和預防
門診手術中心和診所正在使用內視鏡再處理來滿足對用於患者照護的經濟高效的無菌設備不斷成長的需求,減少對環境的影響,並遵守嚴格的衛生法規。隨著內視鏡設計變得越來越複雜,它們還需要先進的再處理解決方案來進行有效滅菌,這種需求隨著患者數量的增加而不斷成長。鑑於使用內視鏡的醫療科室多種多樣,例如泌尿系統、泌尿科和呼吸系統醫療設備,醫院的最終用戶群涵蓋了更廣泛的醫療保健提供者。該群體包括參與內視鏡處理、使用、清洗和再處理各階段的內科醫生、外科醫生、內視鏡護理師、麻醉師和設施內務人員。醫院對再處理內視鏡的需求主要是出於病人安全考慮,因為醫院為大量患有多種疾病和合併症的患者提供服務。它也受到對有效感染控制和預防的日益重視以及保持醫療設備無菌的監管要求的影響。醫院對微創手術的需求不斷增加,導致內視鏡的使用增加,這反過來又增加了對有效再處理的需求。在這兩種情況下,人們越來越認知到專業再處理內視鏡的相關性和好處是一個令人鼓舞的趨勢。
區域洞察
由於胃腸道疾病、癌症和其他慢性病等需要內視鏡檢查的疾病的盛行率不斷上升,美洲尤其是北美的內視鏡再處理市場呈現持續成長的趨勢。微創手術和技術進步的不斷成長趨勢正在推動美洲內視鏡再處理市場的成長。全部區域不斷發展的醫療基礎設施以及不斷增加的旨在早期疾病檢測的政府和非營利組織舉措正在推動內視鏡檢查的需求。然而,成本限制和技術人員缺乏可能會在一定程度上阻礙市場成長。歐洲、中東和非洲地區是內視鏡再處理市場的主要參與者,其中歐洲處於領先地位。歐洲成長的背後是人口老化、內視鏡手術需求的快速成長以及強大的技術基礎。另一方面,中東和非洲市場目前成長相對緩慢,主要是由於醫療保健機會有限和技術採用延遲。儘管如此,由於挖掘潛在市場和增加醫療基礎設施投資,仍有成長前景。
FPNV定位矩陣
FPNV定位矩陣對於評估內視鏡再處理市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對內視鏡再處理市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭評估及資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行綜合評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.內視鏡再處理市場的市場規模與預測為何?
2.在內視鏡再處理市場的預測期間內,有哪些產品、細分市場、應用和領域需要考慮投資?
3.內視鏡再處理市場的技術趨勢和法規結構是什麼?
4.內視鏡再處理市場主要廠商的市場佔有率為何?
5.進入內視鏡後處理市場的合適型態和策略手段是什麼?
[192 Pages Report] The Endoscope Reprocessing Market size was estimated at USD 3.17 billion in 2023 and expected to reach USD 3.45 billion in 2024, at a CAGR 9.08% to reach USD 5.83 billion by 2030.
Endoscope reprocessing is an essential sterilization procedure designed to reduce the risk of infection between uses. An endoscope is a flexible tube with a light and camera attached to it, used for viewing the interior of a person's digestive tract. Following use, endoscopes need to be meticulously cleaned and disinfected to eliminate microbial contamination. The rising prevalence of diseases that require endoscopy procedures, such as gastrointestinal ailments, cancer, and cardiovascular diseases, is driving the growth of the endoscope reprocessing market. With an increasing number of procedures performed, there's an elevated demand for reprocessed endoscopes. Modern automatic reprocessors, equipped with enhanced disinfection and cleaning capabilities, reinforce the effectiveness of infection control procedures. Such advancements readily cater to the growing demand in healthcare settings for patient safety and hygiene. Regulatory organizations, such as the Food and Drug Administration (FDA) and Center for Disease Control (CDC), centralize their standards on endoscope reprocessing around infection control and prevention. The strict implementation of these regulations across healthcare institutions guarantees the safe and standardized practice of endoscope reprocessing, thereby driving market growth. However, the high cost associated with the development of endoscope reprocessing solutions is hindering market growth. The rising introduction of technologically advanced endoscope reprocessing solutions is expected to create opportunities for market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 3.17 billion |
Estimated Year [2024] | USD 3.45 billion |
Forecast Year [2030] | USD 5.83 billion |
CAGR (%) | 9.08% |
Product: Growing usage of detergents & wipes for preventing biofilm build-up and ensuring comprehensive disinfection
Automated endoscope reprocessors (AERs) have revolutionized the endoscope reprocessing industry by standardizing the disinfection process, boosting infection control, and reducing contamination risks. Despite the enhanced efficiency, in-depth research is required to assess the adoption level, cost-effectiveness, and technological advancements in AERs. Detergents & wipes provide critical support to the endoscope reprocessing process, preventing biofilm build-up and ensuring comprehensive disinfection. The impact of factors such as biocompatibility, efficacy, and ease of use on market dynamics needs a thorough examination. Endoscope drying, storage, & transport systems are inherently linked to the reduction in endoscope reprocessing-related infections. Endoscope tracking solutions fortify inventory management, bolster patient safety, and enhance data recording and sharing capabilities. An in-depth assessment of these solutions unearths potential growth sectors, client demands, and technological advancements that will drive future market trends. High-level disinfectants & test strips play a pivotal role in ensuring the sterility of endoscopes.
End-User: Rising adoption of endoscope reprocessing across hospitals with the increasing emphasis on effective infection control and prevention
The ambulatory surgical centers & clinics use endoscope reprocessing with the rising need for cost-effective sterile equipment for patient care, reducing environmental impact and legal compliance for strict hygiene standards. The increasingly complicated design of endoscopes has also necessitated advanced reprocessing solutions for effective sterilization, while the rising patient volume has intensified their need. The end-user group in the hospital setting encompasses a wider range of healthcare providers, considering the diverse departments such as gastroenterology, urology, pulmonology and others where endoscopes are utilized. The group includes physicians, surgeons, endoscopy nurses, anesthesiologists, and institutional housekeeping staff engaged in various stages of endoscope handling, usage, cleaning, and reprocessing. The demand for reprocessed endoscopes in hospitals is significantly driven by patient safety concerns, as hospitals cater to a large volume of patients with diversified diseases and co-morbidities. It is also influenced by the increasing emphasis on effective infection control and prevention, alongside regulatory requirements for maintaining the sterility of medical devices. The growing need for minimally invasive procedures in hospitals has also led to an increase in the use of endoscopes and, consequently, the necessity for their effective reprocessing. In both settings, an encouraging trend is the growing awareness about the relevance and benefits of professionally reprocessed endoscopes.
Regional Insights
The endoscope reprocessing market in the Americas, particularly in North America, demonstrates consistent growth due to the rising prevalence of diseases that require endoscopy procedures, such as gastrointestinal diseases, cancer, and other chronic diseases. The ascending trend of minimally invasive surgeries and technological advancements fuel this growth of the endoscope reprocessing market in the Americas. The evolving healthcare infrastructure across the region and increasing government and non-profit initiatives aimed at promoting early disease detection are driving the demand for endoscopes. However, cost constraints and a lack of skilled personnel could hamper the market's growth to an extent. The EMEA region proves to be a significant player in the endoscope reprocessing market, with Europe leading the realm. Europe's growth is attributed to an aging population, burgeoning demand for endoscope procedures, and a strong technological foundation. On the other hand, the market in the Middle East and Africa currently experiences comparatively slower growth, primarily due to limited access to healthcare and lower technology adoption. Despite this, there exist prospects for growth through potential market untapping and increased investment in healthcare infrastructure.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Endoscope Reprocessing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Endoscope Reprocessing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Endoscope Reprocessing Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Advanced Sterilization Products, Inc. by Johnson & Johnson Services, Inc., ARC Group of Companies Inc., ASP Global Manufacturing GmbH, Belimed AG, BES Healthcare Ltd., Borer Chemie AG, CONMED Corporation, Cook Group Incorporated, Ecolab Inc., Getinge AB, Medalkan, Metrex Research, LLC, Micro-Scientific, LLC, NewCura, Olympus Corporation, Ottomed Endoscopy, Richard Wolf GmbH, Schulke & Mayr GmbH, Shinva Medical Instrument Co., Ltd., Steelco S.p.A., STERIS Corporation, Summit Imaging, Inc., Tuttnauer, and Wassenburg Medical B.V..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Endoscope Reprocessing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Endoscope Reprocessing Market?
3. What are the technology trends and regulatory frameworks in the Endoscope Reprocessing Market?
4. What is the market share of the leading vendors in the Endoscope Reprocessing Market?
5. Which modes and strategic moves are suitable for entering the Endoscope Reprocessing Market?